Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2003
06/19/2003WO2003050107A1 New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
06/19/2003WO2003050104A1 Novel substance fki-1083 and process for producing the same
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003050051A1 Antimicrobial alkali-silicate glass ceramic and the use thereof
06/19/2003WO2003049772A2 Guanidinium transport reagents and conjugates
06/19/2003WO2003049766A2 Method of purifying hepatitis a virus particles and vaccine preparation
06/19/2003WO2003049764A1 Composition for viral preservation
06/19/2003WO2003049763A1 Composition for the preservation of viruses
06/19/2003WO2003049762A2 Immunisation against chlamydia trachomatis
06/19/2003WO2003049760A1 Compositions and method for treating hepatitis virus infection
06/19/2003WO2003049752A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
06/19/2003WO2003049749A1 Treatment of dairy cattle through use of electrochemically activated, aqueous solutions
06/19/2003WO2003049746A2 Combination of cytochome p450 dependent protease inhibitors
06/19/2003WO2003049728A1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation
06/19/2003WO2003049726A1 Respiratory infection prevention and treatment with terpene-containing compositions
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049717A2 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases
06/19/2003WO2003049703A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049690A2 Hiv integrase inhibitors
06/19/2003WO2003049688A2 Bis hydrochloride monohydrate salt of rsv fusion inhibitor
06/19/2003WO2003049675A2 Treating muscle wasting with selective androgen receptor modulators
06/19/2003WO2003035681A3 Mycobacterial genes down-regulated during latency
06/19/2003WO2003028767A3 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions and methods
06/19/2003WO2003026572A3 Crystalline forms of ertapenem sodium
06/19/2003WO2003009777A3 Delivery of therapeutic capable agents
06/19/2003WO2003005960A3 Novel bicyclic and tricyclic cannabinoids
06/19/2003WO2002057315A3 Streptococcal streptolysin s vaccines
06/19/2003WO2002048172A3 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
06/19/2003WO2002043660A3 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
06/19/2003WO2002008244A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
06/19/2003US20030114665 Such as 7-(((5-amino-1,2,4-thiadiazol-3-yl)-(Z)-(fluoro-methoxyimino)acetyl)amino)-3-(imino-1-piperazinylmethyl) methylhydrazono)methyl-3-cephem-4-carboxylic acid
06/19/2003US20030114646 Human cystatin F
06/19/2003US20030114481 Respiratory syncytial virus
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114472 Viricides
06/19/2003US20030114470 Crystalline forms of valacyclovir hydrochloride
06/19/2003US20030114464 Synergistic mixture containing quinolone antibiotic such as floxacin; also fungicide; topical applying to eye
06/19/2003US20030114460 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/19/2003US20030114458 Antibacterial agents
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114443 Viricides, Aids therapy
06/19/2003US20030114439 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/19/2003US20030114423 Arylamines as inhibitors of chemokine binding to US28
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030114393 Use of steroidal alkaloids to reverse multidrug resistance
06/19/2003US20030114369 HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides
06/19/2003US20030114364 Administering lactoferrin and glycomacropeptide; microbiocides
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113742 Methods and compositions for the modulation of biofilm formation
06/19/2003US20030113418 Dry product of defatted whole egg of eggs of a fowl bred by feeding a feed having blended therein dry product of Angelica keiskei, a dry product of brown algae, and optionally a dry product of Theaceae Camellia.
06/19/2003US20030113393 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
06/19/2003US20030113385 Use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
06/19/2003US20030113384 Antimicrobial compositions for mastitis control
06/19/2003US20030113366 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/19/2003US20030113359 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix
06/19/2003US20030113350 Immunocarrier and a conjugate of a polysaccharide or glycopeptide surface antigen from a bacterial strain
06/19/2003US20030113348 Non-laboratory strain used in the manufacture of a medicament for the oncolytic treatment of cancer; anticancer agents
06/19/2003US20030113338 Immunogenic detoxified mutant e. coli lt-a toxin
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113323 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity
06/19/2003US20030113297 Contains active ingredients from the fruiting body and the mycelium of Antrodia Cinnamomea, which is a kind of mushroom that grows inside an unique plant in Taiwan, a Cinnamomum kanehirae tree, cures alcohol related liver cancer
06/19/2003US20030113292 Interferon-gamma-inducing factor (IGIF/IL-18); promoting differentiation of CD4-lymphocytes
06/19/2003US20030113278 Treatment of excessive radiation (e.g. sunburn) exposure
06/19/2003CA2784260A1 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003CA2470104A1 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
06/19/2003CA2469901A1 Use of a labelled ligand having specificity for the human cd4 molecule to produce a diagnostic agent for analysing migration and/or distribution patterns of cell populations
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469679A1 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003CA2469620A1 Immunisation against chlamydia trachomatis
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2469491A1 Composition for viral preservation
06/19/2003CA2469340A1 Treating muscle wasting with selective androgen receptor modulators
06/19/2003CA2469336A1 Guanidinium transport reagents and conjugates
06/19/2003CA2469304A1 6-o acyl ketolide antibacterials
06/19/2003CA2468892A1 Vitamin d analogues
06/19/2003CA2468659A1 Urea substituted imidazopyridines
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468297A1 Method of purifying hepatitis a virus particles and vaccine preparation
06/19/2003CA2468202A1 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003CA2468190A1 New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
06/19/2003CA2468174A1 Amide substituted imidazopyridines
06/19/2003CA2468164A1 Sulfonamido substituted imidazopyridines
06/19/2003CA2467914A1 Prion inhibiting peptides and derivatives thereof
06/19/2003CA2464341A1 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
06/18/2003EP1319666A1 Novel antibacterial compounds
06/18/2003EP1319406A1 Novel antibacterial compounds
06/18/2003EP1319182A2 G-csf analog compositions and methods
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319014A1 Antisense modulation of flip-c expression
06/18/2003EP1319011A1 Triazolo-epothilones
06/18/2003EP1319009A1 Intermediates in cephalosporin production
06/18/2003EP1319008A2 Water soluble rapamycin esters
06/18/2003EP1319001A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
1 ... 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 ... 1798